Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety Study of High Doses of Zinc in ALS Patients

This study has been completed.
Information provided by (Responsible Party):
Phoenix Neurological Associates, LTD Identifier:
First received: December 10, 2010
Last updated: March 9, 2012
Last verified: March 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2012
  Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)